In mice infected with a virus that causes nerve damage, triggering the innate immune system with a synthetic viral RNA (poly(I:C)) early on reduces the immune system’s later attack on the nervous system, similar to the effect of interferon-beta, by reducing inflammatory signals and immune cell infiltration.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether poly(I:C) administration during early viral infection consistently reduces autoimmune demyelination across multiple animal models and whether this effect is reproducible across dosing regimens and timing.
A systematic review and meta-analysis of all published RCTs in mice or rats with TMEV or EAE models comparing poly(I:C) (dose: 150 μg, route: intraperitoneal, timing: days 0–4 post-infection) versus controls, with standardized outcomes: PLP139–151 T cell proliferation, CNS IL-10, CD4+ infiltration, and demyelination scores at day 63.
Whether poly(I:C) causally prevents autoimmune demyelination in TMEV-infected mice when administered early, independent of IFN-β.
A double-blind, placebo-controlled RCT in 60+ female SJL mice, randomized to receive intraperitoneal poly(I:C) (150 μg) or saline at days 0 and 4 post-TMEV infection, with blinded outcome assessment of PLP139–151-specific T cell proliferation (ELISPOT), CNS IL-10 (qPCR), CD4+ infiltration (flow cytometry), and demyelination (histology) at day 63.
Whether the magnitude of early innate immune activation (measured by IFN-β or cytokine induction) after poly(I:C) predicts the degree of subsequent autoimmune suppression in TMEV-infected mice.
A prospective cohort study of 100+ SJL mice infected with TMEV and treated with poly(I:C) at day 0, measuring CNS IFN-β, IL-6, and MIP-1α at day 4, then tracking PLP139–151 T cell response and demyelination at day 63, adjusting for viral load and sex.
Whether mice with minimal demyelination after TMEV infection and poly(I:C) treatment have higher early CNS IFN-β levels than mice with severe disease.
A case-control study comparing CNS IFN-β levels at day 4 post-infection in 30 mice with minimal demyelination (score ≤1) versus 30 with severe disease (score ≥3) after poly(I:C) treatment, matched for viral load and sex.
Whether there is a correlation between CNS IFN-β levels at day 7 and PLP139–151 T cell reactivity at day 63 in mice treated with poly(I:C) after TMEV infection.
A cross-sectional analysis of 50 TMEV-infected SJL mice treated with poly(I:C), measuring CNS IFN-β at day 7 and PLP139–151 T cell proliferation at day 63 in the same animals.